Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery

[1]  G. Klein,et al.  Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course , 1983, Cancer Immunology, Immunotherapy.

[2]  G. Klein,et al.  Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course , 1983, Cancer Immunology, Immunotherapy.

[3]  E. Klein,et al.  Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes , 1982, International journal of cancer.

[4]  P. Schofield,et al.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma. , 1981, British Journal of Cancer.

[5]  H. Strander,et al.  Can historical controls be used in current clinical trials in osteosarcoma?. Metastases and survival in a historical and a concurrent group. , 1980, International journal of radiation oncology, biology, physics.

[6]  B. Vose.  Specific T-cell-mediated killing of autologous lung tumour cells. , 1980, Cellular immunology.

[7]  E. Klein,et al.  Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity. , 1979, Journal of the National Cancer Institute.

[8]  E. Klein,et al.  Restricted autologous lymphocytotoxicity in lung neoplasia. , 1978, British Journal of Cancer.

[9]  R. Connor,et al.  The relative proliferation index as a more sensitive parameter for evaluating lymphoproliferative responses of cancer patients to mitogens and alloantigens , 1977, International journal of cancer.

[10]  D. Taramelli,et al.  Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes , 2004, Cancer Immunology, Immunotherapy.

[11]  K. Cantell,et al.  Adjuvant interferon treatment of human osteosarcoma. , 1982, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.